Your browser doesn't support javascript.
loading
Safety and efficacy of CRISPR-based non-viral PD1 locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-human phase I study.
Hu, Yongxian; Zu, Cheng; Zhang, Mingming; Wei, Guoqing; Li, Wei; Fu, Shan; Hong, Ruimin; Zhou, Linghui; Wu, Wenjun; Cui, Jiazhen; Wang, Dongrui; Du, Bing; Liu, Mingyao; Zhang, Jiqin; Huang, He.
Afiliación
  • Hu Y; Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zu C; Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, 311121, China.
  • Zhang M; Institute of Haematology, Zhejiang University, Hangzhou, China.
  • Wei G; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Li W; Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Fu S; Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, 311121, China.
  • Hong R; Institute of Haematology, Zhejiang University, Hangzhou, China.
  • Zhou L; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Wu W; Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Cui J; Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, 311121, China.
  • Wang D; Institute of Haematology, Zhejiang University, Hangzhou, China.
  • Du B; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Liu M; Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhang J; Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, 311121, China.
  • Huang H; Institute of Haematology, Zhejiang University, Hangzhou, China.
EClinicalMedicine ; 60: 102010, 2023 Jun.
Article en En | MEDLINE | ID: mdl-37251628
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: EClinicalMedicine Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: EClinicalMedicine Año: 2023 Tipo del documento: Article